Subconjunctival ranibizumab at a single dose of 0.3 mg was not associated with any side effects but had no effect on the extent of vascularization of primary pterygium in our study.

Purpose: To present clinical results of toric intraocular lens (IOL) implantation for preexisting astigmatism correction and determine the time of any postoperative rotation. Patients and methods: Twenty-nine eyes of 19 patients underwent uncomplicated phacoemulsification and were implanted with an Acrysof © toric IOL. Uncorrected visual acuity, residual astigmatism, and postoperative rotation of the IOL were estimated one and six months after the operation. Results: Uncorrected visual acuity was 0.5 in 26 of 29 eyes (89.7%) and 0.8 in 19 of 29 patients (65.5%). The mean toric IOL axis rotation was 2.2 ± 1.5° (range 0.6-7.8°) one month postoperation and 2.7 ± 1.5° (range 0.9-8.4°) six months postoperation. Conclusion: Implantation of one-piece hydrophobic acrylic toric IOLs appears to have acceptable stability, which encourages visual outcome and emerges as an attractive alternative for correction of refractive astigmatism.

Summary The aim of this presentation is to show the use of the new technologies in the investigation of Macular Interface Disorders Methods: I will present various cases with the most common vitreomacular interface pathologyResults: I will demonstrate tips in order to make the new technology more useful in the investigation of Macular interfaceDiscussion: in the era of new technology Macular interface become an easier to investigate subject in order to choose the best treatment for the patient.